FDA Clarifies NSE Rate For Reprocessed Single-Use Device 510(k)s

FDA expects to meet its Nov. 1 target for review of reprocessor supplemental validation submissions, even though a lack of reuse standards is complicating the agency's task

More from Archive

More from Medtech Insight